| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Gastric Cancer |
0 |
0.62 |
| Hepatocellular Carcinoma |
0 |
0.51 |
| Microsatellite Instability-High |
0 |
0.51 |
| Cancer |
0 |
0.49 |
| Chemotherapy |
0 |
0.46 |
| Biologic Therapy |
0 |
0.45 |
| Colorectal Cancer |
0 |
0.45 |
| Metastasis |
0 |
0.43 |
| Liver Metastases |
0 |
0.42 |
| Microsatellite Instability |
0 |
0.38 |
| Combination Chemotherapy |
0 |
0.35 |
| Toxicology |
0 |
0.34 |
| Tumor |
0 |
0.3 |
| Perioperative Care |
0 |
0.23 |
| Surgery |
0 |
0.15 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.1 |
| Adenocarcinoma |
0 |
0.08 |
| Liver |
0 |
0.08 |
| Platinum |
0 |
0.08 |
| Tyrosine Kinase Inhibitor |
0 |
0.05 |
| Diarrhea |
0 |
0.04 |
| Gastroenteritis |
0 |
0.04 |
| Neoadjuvant Therapy |
0 |
0.04 |
| Neurotoxicity |
0 |
0.04 |
| Prognosis |
0 |
0.04 |
| Resection |
0 |
0.04 |
| Tyrosine Kinase |
0 |
0.04 |